THE MOSCOW STUDY: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL OF PARENTERAL TESTOSTERONE UNDECANOATE ON THE METABOLIC SYNDROME AND INFLAMMATION MARKERS